| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Since its inception more than 55 years ago, Memorial Healthcare System has been a leader in providing high-quality healthcare services to South Florida residents. Today, it is the fifth-largest public healthcare system in the nation and highly regarded for its exceptional patient- and family-centered care. Memorial`s patient, physician and employee satisfaction rates are some of the most admired in the country, and the system is recognized as a national leader in quality care. To be a premier clinically integrated delivery system providing access to exceptional patient-and family-centered care, medical education, research and innovation for the benefit of the community we serve.
Quilleer & Blake Advertising is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Jefferson Medical is a Oak Ridge, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
LAB Research Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.